Huayuu Biopharma Completes Series B Funding
The company successfully completed Series B funding .
Hangzhou Huayuu Biopharma Co., Ltd. (HUAYUU) recently announced the completion of Series B funding , led by several renowned investment institutions. The funds will be used to accelerate clinical advancement of core pipelines and industrial base construction.
Related News
Huayuu(HUAYUU) has completed the information registration and certification for ChemicalBook.com
Hangzhou Huayuu Biopharma Co., Ltd.（HUAYUU）has completed the information registration and certification for ChemicalBook.com
Brand identity update of Huayuu Biomedicine
Hangzhou Huayuu Biomedical is a service provider specializing in research and development of bioactive ingredients, focusing on peptides and plant extracts. We provide high-purity raw materials, customized research and development, as well as technical support solutions for the pharmaceutical, health food, and functional cosmetics industries.